Public Health England
20 papers found
Protocol for a phase IV, open-label feasibility study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background therapy (OBT) plus maraviroc or OBT aloneDownload from doi.org
Missing publications? Search for publications with a matching author name.